Relief Therapeutics Holding AG (RLFTF)

[tcm55]

PFE will have $33B in vaccine sales with a MC of $240B. Do you think rlf will be worth 1/6 to 1/3 of that? ($40-$80B?) Is $8K a dose (X3) reasonable?

The possible production increase of RLF-100 / Zyemini implied a lower overall cost and better access. With NRXP only entitled to 20% of the 'Rest of world' business/profits, the huge decrease in the US cases (NRXP areas) and moderate interest by many countries (at best)... Will there be sufficient Efforts made by both RLF and NRXP to create and supply the Market? Actual distribution? Solved logistics? Enough Available patients at the highest level of need?

IDEA #1. Get the dry powder Inhaler figured out ASAP.

Long infusions or nebulizing the current IV formulations are subject to the same tough and expensive sub-zero logistics as PFE vaccines.
PFE was only able to distribute their vaccine with HUGE help from Govs. Pre-paid.